Curex
| Company type | Private |
|---|---|
| Industry | Telehealth, Immunology |
| Founded | 2020 |
| Founder | Gene Kakaulin, Charles Jacoby |
| Headquarters | New York City , United States |
Area served | United States |
Key people | Chet Tharpe (Medical Director) |
| Products | Allergy diagnostics, Immunotherapy prescription and delivery |
Curex is a United States-based telehealth enterprise specializing in the field of immunology, with a concentration on diagnosing and managing allergic conditions. Their services encompass the prescription and home delivery of allergy immunotherapy. Established in 2020 by Gene Kakaulin and Charles Jacoby, Curex is headquartered in New York City. The company provides a virtual platform that connects patients with healthcare professionals for allergy-related care.
History
Curex was launched in 2020 by founders Gene Kakaulin and Charles Jacoby, motivated by their own experiences with allergy shots and allergic reactions. They developed Curex as a telemedicine service dedicated to allergy treatment.
The company maintains a nationwide network of allergists and nurse practitioners, complemented by a mail-order pharmacy that ships allergy immunotherapy and prescribed drugs directly to patients' residences.
Their primary focus is on treating prevalent environmental allergies, including pollen from trees, weeds, and grasses; allergies to pets; as well as indoor allergens such as mold and dust mites. Curex also manages conditions linked to allergies like asthma and atopic dermatitis (eczema). The medical director overseeing clinical operations is Chet Tharpe.
Services
Curex provides allergy diagnostics and supports ImmunoCAP IgE allergy testing, an FDA-approved method that involves collecting blood samples either at home or in a laboratory setting. Additionally, the company offers CLIA-certified self-administered IgE testing kits.
The organization has established partnerships with leading insurance providers such as Aetna, Blue Cross Blue Shield, Anthem, United, and Humana. Their testing primarily targets indoor and outdoor allergens rather than food-related allergens.
After diagnosis, Curex physicians develop individualized treatment regimens which may include immunotherapy options like sublingual drops, tablets, or in-office allergy injections. Patients typically begin with a three-month supply of immunotherapy treatments, with continuous supervision and adjustments provided by Curex medical staff.